AKT1 and breast carcinoma: BF also attenuated the proliferation of breast cancer MCF-7 cells in vitro and in vivo, by inhibiting the PI3K/Akt pathway, and the proliferation of breast cancer MCF-7 cells in vitro and in vivo by inhibiting the PI3K/Akt pathway [117].